Drug Pipeline

Regadenoson Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT03102125 Allograft Dysfunction in Heart Transplant Heart Transplant Failure and Rejection Recruiting
Phase 2
NCT05583721 Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle… Sickle Cell Disease Recruiting
Phase 1/2
NCT04604782 A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients Myocardial Ischemia Recruiting
Sponsors Running Regadenoson Trials
Paul Kim (1) GE Healthcare (1) St. Jude Children's Research Hospital (1)
Disease Areas
Coronary Artery Disease (1) Sickle Cell Disease (1)
Get alerts when Regadenoson trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free